Early onset of cannabis use and violent behavior in psychosis.

European Psychiatry : the Journal of the Association of European Psychiatrists
Valerie MoulinP Conus

Abstract

Although evidence from psychosis patients demonstrates the adverse effects of cannabis use (CU) at a young age and that the rate of CU is high in subgroups of young violent patients with psychotic disorders, little is known about the possible effect of the age of onset of CU on later violent behaviors (VB). So, we aimed to explore the impact of age at onset of CU on the risk of displaying VB in a cohort of early psychosis patients. Data were collected prospectively over a 36-month period in the context of an early psychosis cohort study. A total of 265 patients, aged 18-35 years, were included in the study. Logistic regression was performed to assess the link between age of onset of substance use and VB. Among the 265 patients, 72 had displayed VB and 193 had not. While violent patients began using cannabis on average at age 15.29 (0.45), nonviolent patients had started on average at age 16.97 (0.35) (p = 0.004). Early-onset CU (up to age 15) was a risk factor for VB (odds ratio = 4.47, confidence interval [CI]: 1.13-20.06) when the model was adjusted for age group, other types of substance use, being a user or a nonuser and various violence risk factors and covariates. History of violence and early CU (until 15) were the two m...Continue Reading

References

Jan 1, 1990·Schizophrenia Bulletin·R E DrakeM S Beaudett
Oct 4, 2000·Archives of General Psychiatry·L ArseneaultP A Silva
May 2, 2001·The British Journal of Psychiatry : the Journal of Mental Science·J MiltonJ Brewin
Nov 26, 2002·BMJ : British Medical Journal·Louise ArseneaultTerrie E Moffitt
Mar 25, 2004·The Australian and New Zealand Journal of Psychiatry·L KoenD J H Niehaus
Jun 25, 2005·Schizophrenia Bulletin·Cécile HenquetJim van Os
Jul 5, 2005·Acta Psychiatrica Scandinavica·M LambertB G Schimmelmann
Aug 30, 2005·Schizophrenia Research·Robert F FerdinandFrank C Verhulst
Dec 14, 2005·The Australian and New Zealand Journal of Psychiatry·Alison R YungJoe Buckby
Mar 21, 2007·The Medical Journal of Australia·Olav B NielssenRobert A Hayes
May 3, 2008·Acta Psychiatrica Scandinavica·M KoningsJ Van Os
Apr 24, 2009·Schizophrenia Bulletin·Johanna KoskinenJouko Miettunen
Jan 16, 2010·The Australian and New Zealand Journal of Psychiatry·Anthony W F HarrisJohn Brennan
Apr 8, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sara DragtDon H Linszen
Jun 16, 2010·International Journal of Law and Psychiatry·Alicia SpidelJohn C Yuille
Oct 12, 2010·Psychological Medicine·C D SchubartM P M Boks
Jan 7, 2011·Schizophrenia Research·Matthew M Large, Olav Nielssen
Feb 9, 2011·Archives of General Psychiatry·Matthew LargeOlav Nielssen
May 3, 2011·Neuroscience and Biobehavioral Reviews·Paola CasadioMarta Di Forti
May 13, 2011·Schizophrenia Bulletin·Jan Volavka, Leslie Citrome
Jan 1, 2011·Journal of Drug Education·Michael K Ostrowsky
May 11, 2013·The Australian and New Zealand Journal of Psychiatry·Matthew M LargeOlav B Nielssen
Sep 13, 2013·Frontiers in Psychiatry·Michel LejoyeuxHoucine Embouazza
Aug 20, 2015·The Australian and New Zealand Journal of Psychiatry·Hannah MylesMatthew Large
Jan 19, 2016·The Lancet. Psychiatry·Tabea SchoelerSagnik Bhattacharyya
Mar 11, 2016·Psychological Medicine·T SchoelerS Bhattacharyya
Sep 30, 2016·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Vajira Dharmawardene, David B Menkes
Jul 13, 2017·Schizophrenia Research·Mary F BrunetteJohn M Kane
Oct 7, 2017·Frontiers in Psychiatry·Jules R DugréAlexandre Dumais
Nov 17, 2017·Early Intervention in Psychiatry·Valerie MoulinPhilippe Conus
Jan 22, 2018·European Psychiatry : the Journal of the Association of European Psychiatrists·V MoulinP Conus
Apr 24, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Charlie RiouxJean Richard Séguin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

stats
R environment for statistical computing

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.